Copper(II) complexes of methimazole, an anti Grave's disease drug. Synthesis, characterization and its potential biological behavior as alkaline phosphatase inhibitor.
Biometals
; 23(2): 255-64, 2010 Apr.
Article
em En
| MEDLINE
| ID: mdl-20012553
ABSTRACT
Methimazole (MeimzH) is an anti-thyroid drug and the first choice for patients with Grave's disease. Two new copper(II) complexes of this drug [Cu(MeimzH)(2)(NO(3))(2)]*0.5H(2)O and [Cu(MeimzH)(2)(H(2)O)(2)](NO(3))(2)*H(2)O were synthesized and characterized by elemental analysis, dissolution behavior, thermogravimetric analysis and UV-vis, diffuse reflectance, FTIR and EPR spectroscopies. As it is known that copper(II) cation can act as an inhibitor of alkaline phosphatase (ALP), the inhibitory effect of methimazole and its copper(II) complexes on ALP activity has also been investigated.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antitireóideos
/
Doença de Graves
/
Cobre
/
Fosfatase Alcalina
/
Metimazol
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article